CN105394282A - 一种可降压降糖降脂的葛根保健茶 - Google Patents
一种可降压降糖降脂的葛根保健茶 Download PDFInfo
- Publication number
- CN105394282A CN105394282A CN201510856670.8A CN201510856670A CN105394282A CN 105394282 A CN105394282 A CN 105394282A CN 201510856670 A CN201510856670 A CN 201510856670A CN 105394282 A CN105394282 A CN 105394282A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- blood
- medicine
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001603 reducing effect Effects 0.000 title claims abstract description 20
- 230000036541 health Effects 0.000 title claims abstract description 19
- 210000004369 blood Anatomy 0.000 title abstract description 70
- 239000008280 blood Substances 0.000 title abstract description 70
- 230000036772 blood pressure Effects 0.000 title abstract description 10
- 150000002632 lipids Chemical class 0.000 title abstract description 10
- 241001122767 Theaceae Species 0.000 title description 16
- 241000405414 Rehmannia Species 0.000 claims abstract description 22
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 22
- 244000197580 Poria cocos Species 0.000 claims abstract description 17
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 17
- 241000756943 Codonopsis Species 0.000 claims abstract description 16
- 241001546929 Campsis grandiflora Species 0.000 claims abstract description 14
- 235000001405 Artemisia annua Nutrition 0.000 claims abstract description 13
- 240000000011 Artemisia annua Species 0.000 claims abstract description 13
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 13
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 13
- 241000735527 Eupatorium Species 0.000 claims abstract description 12
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 12
- 244000269722 Thea sinensis Species 0.000 claims abstract 8
- 244000046146 Pueraria lobata Species 0.000 claims description 61
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 61
- 239000002994 raw material Substances 0.000 claims description 18
- 230000003071 parasitic effect Effects 0.000 claims description 16
- 241001506371 Kadsura Species 0.000 claims description 15
- 241000488974 Loranthus Species 0.000 claims description 15
- 235000008113 selfheal Nutrition 0.000 claims description 15
- 241000132012 Atractylodes Species 0.000 claims description 14
- 240000007164 Salvia officinalis Species 0.000 claims description 14
- 235000005412 red sage Nutrition 0.000 claims description 14
- 244000226566 Psoralea corylifolia Species 0.000 claims description 13
- 241001116757 Pyrrosia lingua Species 0.000 claims description 13
- 241000218989 Trichosanthes Species 0.000 claims description 12
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims description 11
- 240000003582 Platycodon grandiflorus Species 0.000 claims description 11
- 244000179560 Prunella vulgaris Species 0.000 claims 3
- 239000003814 drug Substances 0.000 abstract description 56
- 230000000694 effects Effects 0.000 abstract description 50
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 35
- 230000008901 benefit Effects 0.000 abstract description 19
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 8
- 230000007774 longterm Effects 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 8
- 210000003205 muscle Anatomy 0.000 abstract description 7
- 238000011160 research Methods 0.000 abstract description 5
- 201000001320 Atherosclerosis Diseases 0.000 abstract description 4
- 208000011580 syndromic disease Diseases 0.000 abstract description 4
- 230000001739 rebound effect Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 235000006751 Platycodon Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 241000025505 Pyrrosia Species 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 229930189914 platycodon Natural products 0.000 abstract 1
- 239000008517 radix Trichosanthis Substances 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 38
- 201000010099 disease Diseases 0.000 description 32
- 210000003734 kidney Anatomy 0.000 description 30
- 239000000284 extract Substances 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 208000002193 Pain Diseases 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 19
- 230000036407 pain Effects 0.000 description 19
- 210000000952 spleen Anatomy 0.000 description 18
- 210000004072 lung Anatomy 0.000 description 17
- 230000007812 deficiency Effects 0.000 description 16
- 206010020772 Hypertension Diseases 0.000 description 15
- 235000013616 tea Nutrition 0.000 description 15
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 14
- 229940079593 drug Drugs 0.000 description 14
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 14
- 230000035922 thirst Effects 0.000 description 14
- 206010062717 Increased upper airway secretion Diseases 0.000 description 13
- 206010037660 Pyrexia Diseases 0.000 description 13
- 208000026435 phlegm Diseases 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 12
- 240000002800 Sanicula europaea Species 0.000 description 12
- 208000002173 dizziness Diseases 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 12
- 230000027939 micturition Effects 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 230000002218 hypoglycaemic effect Effects 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 230000001077 hypotensive effect Effects 0.000 description 9
- 208000009205 Tinnitus Diseases 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 8
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 8
- 230000034994 death Effects 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 229930182478 glucoside Natural products 0.000 description 8
- 150000008131 glucosides Chemical class 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 231100000886 tinnitus Toxicity 0.000 description 8
- 206010046788 Uterine haemorrhage Diseases 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 7
- 238000009835 boiling Methods 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 201000001881 impotence Diseases 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- BWWAFUZQSLIIIH-UHFFFAOYSA-N 2-phenyl-3H-chromen-3-id-4-one Chemical compound O1C(=[C-]C(=O)C2=CC=CC=C12)C1=CC=CC=C1 BWWAFUZQSLIIIH-UHFFFAOYSA-N 0.000 description 6
- 208000008967 Enuresis Diseases 0.000 description 6
- 208000037093 Menstruation Disturbances Diseases 0.000 description 6
- 206010027339 Menstruation irregular Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 241000219780 Pueraria Species 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 201000005577 familial hyperlipidemia Diseases 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 6
- 201000001421 hyperglycemia Diseases 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 229930182490 saponin Natural products 0.000 description 6
- 150000007949 saponins Chemical class 0.000 description 6
- 235000017709 saponins Nutrition 0.000 description 6
- 230000002269 spontaneous effect Effects 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 5
- 206010053615 Thermal burn Diseases 0.000 description 5
- 208000031971 Yin Deficiency Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 150000003626 triacylglycerols Chemical class 0.000 description 5
- 239000011800 void material Substances 0.000 description 5
- 206010049865 Achromotrichia acquired Diseases 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 241000209020 Cornus Species 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 206010022998 Irritability Diseases 0.000 description 4
- 206010027514 Metrorrhagia Diseases 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 235000007240 daidzein Nutrition 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 230000000249 desinfective effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 210000005229 liver cell Anatomy 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000000967 suction filtration Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 241001473306 Eupatorium perfoliatum Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000001953 Hypotension Diseases 0.000 description 3
- 206010022489 Insulin Resistance Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 240000008866 Ziziphus nummularia Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000003028 elevating effect Effects 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 229940074391 gallic acid Drugs 0.000 description 3
- 235000004515 gallic acid Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010002368 Anger Diseases 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000005189 Embolism Diseases 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 102000003746 Insulin Receptor Human genes 0.000 description 2
- 108010001127 Insulin Receptor Proteins 0.000 description 2
- AMBQHHVBBHTQBF-UHFFFAOYSA-N Loganin Natural products C12C(C)C(O)CC2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O AMBQHHVBBHTQBF-UHFFFAOYSA-N 0.000 description 2
- 235000008708 Morus alba Nutrition 0.000 description 2
- 208000029549 Muscle injury Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038001 Rebound effect Diseases 0.000 description 2
- 102100028255 Renin Human genes 0.000 description 2
- 108090000783 Renin Proteins 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 101000693619 Starmerella bombicola Lactone esterase Proteins 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- VSJGJMKGNMDJCI-ZASXJUAOSA-N Sweroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)[C@H](CCOC2=O)C2=CO1 VSJGJMKGNMDJCI-ZASXJUAOSA-N 0.000 description 2
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000004631 alopecia areata Diseases 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001147 anti-toxic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000002876 beta blocker Substances 0.000 description 2
- 229940097320 beta blocking agent Drugs 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000007211 cardiovascular event Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 208000016097 disease of metabolism Diseases 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000008838 gegenqinlian Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 229930182489 iridoid glycoside Natural products 0.000 description 2
- 150000008145 iridoid glycosides Chemical class 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000037356 lipid metabolism Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- AMBQHHVBBHTQBF-UOUCRYGSSA-N loganin Chemical compound O([C@@H]1OC=C([C@H]2C[C@H](O)[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AMBQHHVBBHTQBF-UOUCRYGSSA-N 0.000 description 2
- 229940099690 malic acid Drugs 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 210000002464 muscle smooth vascular Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- JVXZRQGOGOXCEC-UHFFFAOYSA-N scutellarein Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 2
- 208000037921 secondary disease Diseases 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 239000007962 solid dispersion Substances 0.000 description 2
- VSJGJMKGNMDJCI-QXSNVGMTSA-N sweroside Natural products OC[C@H]1O[C@H](O[C@@H]2OC=C3[C@@H](CCOC3=O)[C@H]2C=C)[C@H](O)[C@@H](O)[C@@H]1O VSJGJMKGNMDJCI-QXSNVGMTSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960001367 tartaric acid Drugs 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000004916 vomit Anatomy 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000018645 Allium odorum Nutrition 0.000 description 1
- 240000008654 Allium ramosum Species 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 244000252230 Artemisia stelleriana Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 241000759833 Cornus officinalis Species 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 240000007175 Datura inoxia Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 241001065361 Gynostemma Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 241000561709 Kadsura longipedunculata Species 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 241001197778 Tripterygium hypoglaucum Species 0.000 description 1
- 206010046555 Urinary retention Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- -1 carrotene Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- SXYIRMFQILZOAM-HVNFFKDJSA-N dihydroartemisinin methyl ether Chemical compound C1C[C@H]2[C@H](C)CC[C@H]3[C@@H](C)[C@@H](OC)O[C@H]4[C@]32OO[C@@]1(C)O4 SXYIRMFQILZOAM-HVNFFKDJSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000015091 medicinal tea Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000008965 mitochondrial swelling Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229930189407 platycodin Natural products 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 238000011127 radiochemotherapy Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种可降压降糖降脂的葛根保健茶,所述保健茶的各种原料的重量份数为:葛根10~50份,补骨脂10~20份,黄精10~20份,生地10~20份,桑寄生10~20份,丹参10~20份,党参10~20份,石韦10~20份,南五味子10~20份,女贞子10~20份,青蒿10~20份,凌霄花10~20份,茯苓10~20份,夏枯草10~20份,佩兰10~20份,桔梗10~20份,绞股蓝10~20份,天花粉10~20份,白术10~20份。目前西医对糖尿病高脂血症的研究和治疗已取得较大的成果,但长期用药所引起的肝肾功能、消化道症状,肌肉损害及停药后反跳作用仍是治疗的难题。鉴于中医具有辩证论治的特色,中药有毒副作用小的优势,中药保健治疗引起广泛关注。葛根有降血压,降血糖,降血脂,防止动脉粥样硬化,延缓衰老和抗菌等作用。
Description
技术领域
本发明涉及含有来源于植物组份的降糖降脂的保健品,特别涉及一种可降压降糖降脂的葛根保健茶。
背景技术
全国营养状况调查发现,我国18岁以上居民糖尿病患病率为2.6%,全国糖尿病现患病人数达2000多万,在糖尿病患者中,约有20%~90%伴有高脂血症,增加了心血管事件发生的危险性。除了糖尿病、肥胖、胰岛素抵抗、高血压等因素外,脂代谢异常是糖尿病、心血管疾病高发的重要危险因素。因此积极有效地纠正脂代谢紊乱是降低糖尿病患者心血管事件发生率及病死率的重要措施。
继心脑血管、癌症、肿瘤之后,高血糖现已成为人类的第二大杀手。现代城市生活的高速发展,也带来一系列富贵病。其中“三高”和肥胖是困扰人们的首要敌人。“三高症”是指高血压、高血糖(糖尿病)和高血脂症。通常伴随着肥胖。它们是现代社会所派生出来的“富贵病”,可以单独存在,也可能相互关联。如:糖尿病人很容易同时患上高血压或高血脂症,而高血脂又是动脉硬化形成和发展的主要因素,动脉硬化患者血管弹性差加剧血压升高,所以后期都形成了“三高症”。关于三高是什么有资料统计,在中国人的十大死亡原因中,与代谢疾病相关的死亡率就高达35.7%,与“三高”相关的死亡人数也占总死亡人数的27%。高血脂可以引起血管栓塞;高血压可以引起脑出血和脑血管破裂;高血糖可以引起糖尿病。
世界卫生组织曾经明确提出,防止心血管病的第一道防线就是减少“三高”和控制“三高”。很多糖尿病人都伴有高脂血症,因此人们通常把糖尿病与高脂血症称为姐妹病,并认为高血脂是糖尿病的继发症。据统计大约40%的糖尿病病人有脂代谢紊乱。其特点是甘油三酯增高和高密度脂蛋白降低。糖尿病引起血脂增高的原因是由于糖尿病人胰岛素不足时,体内脂酶活泼性是减低的,因此容易血脂增高。另一方面糖尿病本身除糖代谢紊乱外同时还伴脂肪、蛋白质和水、电介质的紊乱。经常有游离脂肪酸从脂肪库中动员出来,使血中甘油三酯及游离脂肪酸浓度增高。再一方面2型糖尿病人进食过多,运动少,促使体内脂类合成增多,这也是造成血脂增高的原因。而肥胖伴高血脂者,由于胰岛素受体数相对减少,从而产生胰岛素抵抗,易诱发糖尿病。血脂增高者还易引起心、脑血管并发症。
葛根总黄酮和葛根素能明显的扩张冠状动脉,可能为直接松弛血管平滑肌的作用。
葛根总黄酮和葛根素能降低正常心肌和心肌梗死区的氧消耗,具有增强心肌对缺血耐受性的作用。
葛根大豆黄素具有抗心率失常的作用,葛根芩连汤体对动物实验性室性早搏有对抗作用。葛根总黄酮能使心率减慢,每搏输出量增加。
葛根素为一种β受体阻断剂,具有明显的降压作用。葛根素对周围微血管和脑血管障碍的血流量具有明显的改善作用,减少血管阻力,增加血流量。
葛根、总黄酮大豆甙元和葛根素对高血压引起的头痛、头晕、耳鸣等症状有明显的疗效。静注葛根浸膏、总黄酮和葛根素,使正常麻醉狗的血压短暂而明显降低。煎剂及醇浸膏给肾型高血压犬灌服,也有一定降压作用。腹腔注射葛根素能明显降低清醒自发高血压大鼠(SHR)的血压并减慢其心率。还可以使SHR的血清肾素活性(PRA)显著降低。大豆甙元固体分散物对麻醉家兔具有相对早而弱的降压作用。
目前西医对糖尿病高脂血症的研究和治疗已取得较大的成果,但长期用药所引起的肝肾功能、消化道症状,肌肉损害及停药后反跳作用仍是治疗的难题。鉴于中医具有辩证论治的特色,中药有毒副作用小的优势,中药治疗引起广泛关注。
中药气味清苦,很多人不愿长期服用;即使服用,是药三分毒,让人长期服用时也产生抗拒心理。怎么把葛根的功效发挥到最大又不伤害人体,并且明显改善口感,使人能接受,是我们迫切需要解决的问题。葛根里面含有大量安全有效的活性物质保健品,能大大降糖降脂,一直是人们期待解决问题的关键。中药葛根具有无毒、能被生物体完全吸收的优点,是我们研究的主要方向。现在市场迫切需要开发一种无毒、能被生物体完全吸收,大大提高人体免疫力的优质的保健品。
发明内容
本发明所要解决的技术问题在于,目前西医对糖尿病高脂血症的研究和治疗已取得较大的成果,但长期用药所引起的肝肾功能、消化道症状,肌肉损害及停药后反跳作用仍是治疗的难题。鉴于中医具有辩证论治的特色,中药有毒副作用小的优势,中药保健治疗引起广泛关注。葛根有降血压,降血糖,降血脂,防止动脉粥样硬化,延缓衰老和抗菌等作用。有明显的利尿、降脂、抗菌与升高血液白细胞的作用,对治疗肝肾亏损所致的眩晕耳鸣、腰酸等症及由于肾阴不足所致的遗精、尿频等症有明显疗效。再加上一些口感清淡,不影响葛根味道的中药,不影响口感使人易于接受,能较好的达到降糖降脂的功效。中药气味清苦,很多人不愿长期服用;即使服用,是药三分毒,让人长期服用时也产生抗拒心理。怎么把葛根的功效发挥到最大又不伤害人体,并且明显改善口感,增强降糖降脂作用,使人能易于接受,是我们迫切需要解决的问题。
为解决上述技术难题,本发明提供一种可降压降糖降脂的葛根保健茶,所述保健茶的各种原料的重量份数为:葛根10~50份,补骨脂10~20份,黄精10~20份,生地10~20份,桑寄生10~20份,丹参10~20份,党参10~20份,石韦10~20份,南五味子10~20份,女贞子10~20份,青蒿10~20份,凌霄花10~20份,茯苓10~20份,夏枯草10~20份,佩兰10~20份,桔梗10~20份,绞股蓝10~20份,天花粉10~20份,白术10~20份。
所述可降压降糖降脂的葛根保健茶,其所述保健茶的各种原料的重量份数可以为:葛根10~50份,补骨脂10~15份,黄精10~15份,生地10~15份,桑寄生10~15份,丹参10~15份,党参10~15份,石韦10~15份,南五味子10~15份,女贞子10~15份,青蒿10~20份,凌霄花10~20份,茯苓10~20份,夏枯草10~20份,佩兰10~20份,桔梗10~20份,绞股蓝10~20份,天花粉10~20份,白术10~20份。
所述可降压降糖降脂的葛根保健茶,其所述保健茶的各种原料的重量份数还可以为:葛根10~50份,补骨脂10~20份,黄精10~20份,生地10~20份,桑寄生10~20份,丹参10~20份,党参10~20份,石韦10~20份,南五味子10~20份,女贞子10~20份,青蒿10~15份,凌霄花10~15份,茯苓10~15份,夏枯草10~15份,佩兰10~15份,桔梗10~15份,绞股蓝10~15份,天花粉10~15份,白术10~15份。
为解决上述技术问题,本发明还提供一种所述可降压降糖降脂的葛根保健茶的制备方法,所述葛根保健茶的制备步骤包括以下方面:
a.葛根的制备;
b.将所述其他原料粉碎、浸泡、加热、回流提取2次;
c.再将其他原料提取的药液浓缩成颗粒剂、粉剂或膏剂;
d.将浓缩的颗粒剂、粉剂或膏剂与制备好的葛根混合,制备成保健茶剂。
所述步骤a中,可以在秋末冬初葛根果皮变红时采收果实,用文火烘或置沸水中略烫后,及时除去果核,干燥,晒干生山萸肉放锅内隔水在80-100℃下蒸30-60分钟,蒸至紫褐色,然后晒干。
所述步骤b中,可以将剩余原料洗净去杂,泡入乙醇,加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述两种提取液合并,减压回收乙醇并浓缩至药液浓度为0.6g生药/mL,抽滤后,滤液的相对密度约为20℃时1.08;减压至0.03-0.08MPa,温度保持在60-80℃,浓缩至相对密度为1.20,温度至60℃-70℃的浸膏。
所述步骤c中,可以把上述步骤提取的浸膏置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含1g生药量,然后加糊精放入制粒机中制粒。
所述步骤d中,可以将制备好的葛根与其他原料制备的颗粒物混合,紫外线灭菌,包装即得。
为解决上述技术问题,本发明也提供一种可降压降糖降脂的葛根保健茶的制备方法,其所述降糖降脂葛根精保健茶的其他原料制成粉剂时步骤为:将其他原料放入5-10倍量乙醇中,浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-120目滤过;再将上述乙醇提取过的其他原料药的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述两种提取液合并,减压回收乙醇,并浓缩至药液浓度为0.6g生药/mL,抽滤后,滤液的相对密度约为20℃时1.08;减压至0.03-0.08MPa,温度保持在60-80℃,浓缩至相对密度为1.20,温度至60℃-70℃的浸膏,放入烘箱内烘干成粉末,紫外线杀菌消毒后与制备好的葛根合并包装。
为解决上述技术问题,本发明再提供一种可降压降糖降脂的葛根保健茶的制备方法,其所述降糖降脂葛根保健茶的其他原料制成膏剂时步骤为:将其他原料放入5-10倍量乙醇中,浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-120目滤过,再经截流分子量为5000-10000的超滤柱超滤,超滤液减压浓缩相对密度为80℃时1.36的浸膏,将制备好的葛根与其他原料制备的颗粒物混合,紫外线灭菌,包装即得。
本发明有益的技术效果在于,汤剂是中医的传统剂型,具有方便随症加减等优点,但汤剂煎煮、携带、使用不方便,且成分煎出不完全,口感差,不适合现代人群用药习惯。由于本发明主要用于防治高脂血症,高血糖,该病属于多因素相关的慢性疾病,病程较长,需长期用药才能达到良好的效果,故应选择服用、携带、使用方便保健茶式饮品更能提高保健作用。葛根有降血压,降血糖,降血脂,防止动脉粥样硬化,延缓衰老和抗菌等作用。葛根味酸、涩性,微温。归肝、肾经。补益肝肾,涩精固脱。用于眩晕耳鸣,腰膝酸痛,阳痿遗精,遗尿尿频,崩漏带下,大汗虚脱,内热消渴,为固涩药,它含有葛根甙、莫罗甙、7-O-甲基莫罗甙、葛根新甙、当药甙、番木鳖甙等环烯醚萜甙类及皂甙、熊果酸、酒石酸、没食子酸、苹果酸、葛根鞣质1、2、3等多种有效成份。有明显的利尿、降脂、抗菌与升高血液白细胞的作用,能较好的达到降糖降脂的功效。
具体实施方式
“三高症”是指高血压、高血糖(糖尿病)和高血脂症。通常伴随着肥胖。它们是现代社会所派生出来的“富贵病”,可能单独存在,也可能相互关联。如:糖尿病人很容易同时患上高血压或高血脂症,而高血脂又是动脉硬化形成和发展的主要因素,动脉硬化患者血管弹性差加剧血压升高,所以后期都形成了“三高症”。关于三高是什么有资料统计,在中国人的十大死亡原因中,与代谢疾病相关的死亡率就高达35.7%,与“三高”相关的死亡人数也占总死亡人数的27%。高血脂可以引起血管栓塞;高血压可以引起脑出血和脑血管破裂;高血糖可以引起糖尿病。世界卫生组织曾经明确提出,防止心血管病的第一道防线就是减少“三高”和控制“三高”。很多糖尿病人都伴有高脂血症,因此人们通常把糖尿病与高脂血症称为姐妹病,并认为高血脂是糖尿病的继发症。据统计大约40%的糖尿病病人有脂代谢紊乱。其特点是甘油三酯增高和高密度脂蛋白降低。糖尿病引起血脂增高的原因是由于糖尿病人胰岛素不足时,体内脂酶活泼性是减低的,因此容易血脂增高。另一方面糖尿病本身除糖代谢紊乱外同时还伴脂肪、蛋白质和水、电介质的紊乱。经常有游离脂肪酸从脂肪库中动员出来,使血中甘油三酯及游离脂肪酸浓度增高。再一方面2型糖尿病人进食过多,运动少,促使体内脂类合成增多,这也是造成血脂增高的原因。而肥胖伴高血脂者,由于胰岛素受体数相对减少,从而产生胰岛素抵抗,易诱发糖尿病。血脂增高者还易引起心、脑血管并发症。
《本草纲目》载:“葛根,主治心下邪气寒热,温中,逐寒温痹,去三虫,久服轻身;有强阴益精、安五脏、通九窍、止小便淋沥之功;久服明目、强力长年”。境内葛根,古自有之。清康熙《绩修商》及乾隆《直隶商州总志》均有记载,且冠以“佳”字。葛根,又名山芋肉、药枣、实枣儿、枣皮、肉枣等,为我国常用名贵中药材,应用历史悠久。它以其补力平和、壮阳而不助火,滋阴而不腻膈,收敛而不留邪等特殊功效被历代医学所喜用。张仲景以葛根为君创制了“金匮肾气丸”。据化学分析,葛根含有生理活性较强的葛根甙、酒石酸、没食子酸、苹果酸、树酯、鞣质和多种维生素等有效成分,具有增强免疫、抗炎、抗菌等药理作用,是中医临床中常用的一味药。
葛根味酸、涩性,微温。归肝、肾经。补益肝肾,涩精固脱。用于眩晕耳鸣,腰膝酸痛,阳痿遗精,遗尿尿频,崩漏带下,大汗虚脱,内热消渴,为固涩药,它含有葛根甙、莫罗甙、7-O-甲基莫罗甙、葛根新甙、当药甙、番木鳖甙等环烯醚萜甙类及皂甙、熊果酸、酒石酸、没食子酸、苹果酸、葛根鞣质1、2、3等多种有效成份。有明显的利尿、降脂、抗菌与升高血液白细胞的作用,对治疗肝肾亏损所致的眩晕耳鸣、腰酸等症及由于肾阴不足所致的遗精、尿频等症有明显疗效。又因其具有收敛止血功效被常用于妇女体虚所致的月经过多,崩漏带下等症,对男科、妇科的常见病均有很好的治疗作用,大量用于补益药物的生产,故被列为国药四十种大宗品种之一,在中医药界有着广泛的市场。
葛根总黄酮和葛根素能明显的扩张冠状动脉,可能为直接松弛血管平滑肌的作用。
葛根总黄酮和葛根素能降低正常心肌和心肌梗死区的氧消耗,具有增强心肌对缺血耐受性的作用。
葛根大豆黄素具有抗心率失常的作用,葛根芩连汤体对动物实验性室性早搏有对抗作用。葛根总黄酮能使心率减慢,每搏输出量增加。
葛根素为一种β受体阻断剂,具有明显的降压作用。葛根素对周围微血管和脑血管障碍的血流量具有明显的改善作用,减少血管阻力,增加血流量。
葛根、总黄酮大豆甙元和葛根素对高血压引起的头痛、头晕、耳鸣等症状有明显的疗效。静注葛根浸膏、总黄酮和葛根素,使正常麻醉狗的血压短暂而明显降低。煎剂及醇浸膏给肾型高血压犬灌服,也有一定降压作用。腹腔注射葛根素能明显降低清醒自发高血压大鼠(SHR)的血压并减慢其心率。还可以使SHR的血清肾素活性(PRA)显著降低。大豆甙元固体分散物对麻醉家兔具有相对早而弱的降压作用。
党参为中国常用的传统补益药,古代以山西上党地区出产的党参为上品,具有补中益气,健脾益肺之功效。现代研究,党参含多种糖类、酚类、甾醇、挥发油、黄芩素葡萄糖甙、皂甙及微量生物碱,具有增强免疫力、扩张血管、降脂、改善微循环、增强造血功能等作用。此外对化疗放疗引起的白细胞下降有提升作用。党参具有补中益气,健脾益肺的功效。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴等。《本草从新》记载:“补中益气、和脾胃、除烦渴。中气微弱,用以调补,甚为平妥。”
茯苓味甘、淡、性平,入药具有利水渗湿、益脾和胃、宁心安神之功用。现代医学研究:茯苓能增强机体免疫功能,茯苓多糖有明显的抗肿瘤及保肝脏作用。茯苓性味甘淡平,入心、肺、脾经。具有渗湿利水,健脾和胃,宁心安神的功效。可治小便不利,水肿胀满,痰饮咳逆,呕逆,恶阻,泄泻,遗精,淋浊,惊悸,健忘等症。茯苓之利水,是通过健运脾肺功能而达到的,与其它直接利水的中药不同。用于脾虚泄泻,带下茯苓既能健脾,又能渗湿,对于脾虚运化失常所致泄泻、带下,应用茯苓有标本兼顾之效,常与党参、白术、山药等配伍。有可用为补肺脾,治气虚之辅佐药。
丹参苦,微寒。归心、肝经。祛瘀止痛,活血通经,清心除烦。用于月经不调,经闭痛经,症瘕积聚,胸腹刺痛,热痹疼痛,疮疡肿痛,心烦不眠。用于胸肋胁痛,风湿痹痛,症瘕结块,疮疡肿痛,跌仆伤痛,月经不调,经闭痛经,产后瘀痛等。治疗胸肋疼痛、症瘕结块,以及月经不调、经闭经痛具有良效。《纲目》载:丹参,按《妇人明理论》云,四物汤治妇人病,不问产前产后,经水多少,皆可通用,惟一味丹参散,主治与之相同。盖丹参能破宿血,补新血,安生胎,落死胎,止崩中滞下,调经脉。丹参主要成分丹参酮有扩张血管、改善循环、解除血管内凝血等作用,具有活血化痕之功效,并能促进肝脏血液循环,利于肝细胞再生。
白术能显著地增强小肠平滑肌的收缩幅度、收缩频率,延长小肠平滑肌在缺氧情况下的收缩时间,调整胃肠运动功能,具有抗溃疡、保肝和增强机体免疫功能的作用。白术味苦、甘,温。归脾、胃经。主治健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。白术对瘤细胞有细胞毒作用,能降低瘤细胞的增殖率,减低瘤组织的侵袭性,提高机体抗肿瘤反应的能力。《药性论》载其:君,味甘,辛,无毒。能主大风痹,多年气痢,心腹胀痛,破消宿食,开胃,去痰涎,除寒热,止下泄。主面光悦,驻颜,去黑。治水肿胀满,吐呕逆,腹内冷痛,吐泻不住,及胃气虚冷痢。
桑寄生味甘,性平。归肺;胃经。滋阴润肺;养胃生津。燥咳;劳嗽;热病阴液耗伤之咽干口渴;内热消渴;阴虚外感;头昏眩晕;筋脉挛痛。桑寄生味甘多脂,质柔而润,是一味养阴生津的良药。桑寄生中所含的维生素A,改善干裂、粗糙的皮肤状况,使之柔软润滑。起到美容护肤的作用。《纲目》:“主风温自汗灼热,及劳疟寒热,脾胃虚乏,男子小便频数,失精,一切虚损。”
南五味子辛微苦甘,平功能主治:理气解郁,调经止痛。用于肝郁气滞,胸、胁、脘腹胀痛,消化不良,月经不调,经闭痛经,寒疝腹痛,乳房胀痛。《纲目》载其:散时气寒疫,利三焦,解六郁,消饮食积聚,痰饮痞满,跗肿,腹胀,脚气,止心腹、肢体、头、目、齿、耳诸痛,痈疽疮疡,吐血,下血,尿血,妇人崩漏带下,月候不调,胎前产后百病。
黄精以根茎入药。具有补气养阴,健脾,润肺,益肾功能。用于治疗脾胃虚弱,体倦乏力,口干食少,肺虚燥咳,精血不足,内热消渴等症。对于糖尿病很有疗效。酒黄精又称炙黄精。为净黄精加酒和黑豆等辅料蒸后切片晒干入药者。兼有遁经络之功。黄精具有降血压,降血糖,降血脂,防止动脉粥样硬化,延缓衰老和抗菌等作用,黄精多糖具有免疫激活作用。用于阴虚肺燥,干咳少痰,及肺肾阴虚的劳嗽久咳等。用于脾胃虚弱。既补脾阴,又益脾气,用于肾虚精亏得头晕,腰膝酸软,须发早白及消渴等。黄精壮筋骨,益精髓,变白发;适宜用于肺阴不足所致的咳嗽痰少,干咳无痰,咳血等症。
补骨脂温肾助阳,纳气,止泻。用于阳痿遗精,遗尿尿频,腰膝冷痛,肾虚作喘,五更泄泻;外用治白癜风,斑秃。芳香性中药。补肾助阳;纳气平喘;温脾止泻。主肾阳不足;下元虚冷;腰膝冷痛;阳痿遗精;尿频;遗尿;肾不纳气;虚喘不止;脾肾两虚;大便久泻;外用于白癜风;斑秃;银屑病。补骨脂又名破故纸、胡韭子,为豆科植物补骨脂的果实,其性温,味辛,入肾经,具有补肾助阳的功效,用于治疗肾虚冷泻、遗尿、滑精、小便频数、阳痿、腰膝冷痛、虚寒喘嗽等症,是一味壮火益土的常用要药。《本草经疏》:补骨脂,能暖水脏;阴中生阳,壮火益土之要药也。其主五劳七伤,盖缘劳伤之病,多起于脾肾两虚,以其能暖水脏、补火以生土,则肾中真阳之气得补而上升,则能腐熟水谷、蒸糟粕而化精微。
生地:生地也叫生地黄,玄参科多年生草本植物地黄RehmanniaglutinosaLibosch.的新鲜或干燥的块根。清热、生津、润燥、滑肠、破瘀、生新、止痛、调经、金疮瘀、凉血、止血;鲜地黄和生地黄的作用是有所不同的。鲜地黄清热生津,可以止血和凉血,经常是用于热病伤阴,吐血、咽喉肿痛、舌绛烦渴、发斑发疹以及衄热等病症。相对于鲜地黄,生地黄是凉血清热,也可以生津,还可以养阴,多用于治疗阴虚内热、骨蒸劳热、舌绛烦渴、发斑发疹等问题。生地性寒,功能为滋阴补肾。不只生津止渴和凉血清热,还对血崩、月经不调、胎动不安、便秘等有作用,凡是血分有热伤阴的人,都可以经常服用。如果想要治疗温热病,可以用生地做清营汤;如果是治疗温病的后期,由于余热还没消尽,应该把生地用来煮青蒿鳖甲汤;另外,针对血热毒盛,斑疹紫黑,温热病严重热入营血的症状,可以服用生地制成的四生丸;一般要养阴生津来治疗内热消渴和便秘的,应该食用生地煮的曾液汤
石韦,拉丁名:FoliumPyrrosiae。利水通淋,清肺泄热。治淋痛,尿血,尿路结石,肾炎,崩漏,痢疾,肺热咳嗽,慢性气管炎,金疮,痈疽。《别录》:″止烦下气,通膀胱满,补五劳,安五藏,去恶风,益精气。″⑨《本草崇原》:石韦,主治劳热邪气者,劳热在骨,邪气在皮,肺肾之所主也。五癃者,五液癃闭,小便不利也。石韦助肺肾之精气,上下相交,水精上濡,则上窍外窍皆通,肺气下化,则水道行而小便利矣。
女贞子用于肝肾阴虚的目暗不明,视力减退,须发早白,腰酸耳鸣及阴虚发热等。本品能补肝肾阴,但药力平和,须缓慢取效。治目暗不明,常配熟地,枸杞等同用,治须发早白,常配桑葚同用,阴虚发热,常配地骨皮。肝肾阴虚,头昏目眩、遗精耳鸣、腰膝酸软,须发早白,冠心病、高脂血症、高血压、慢性肝炎。对肝脏的保护作用研究认为,女贞子含有齐墩果酸,给大鼠皮下注射,可降低血清谷丙转氨酶,对四氯化碳诱发的肝损伤有明显保护作用,并能促进肝细胞再生.齐墩果酸亦可使肝内甘油三酯蓄积减少、肝细胞变性坏死明显减轻、糖原蓄积增加、血清γ球蛋白下降;超微结构可见肝细胞内线粒体肿胀与内质网囊泡变性减轻、肝组织间质炎症反应减弱。
青蒿辛、苦,寒。归肝、心、肺经。功能主治行气化瘀,清心解郁,利胆退黄。用于经闭痛经,胸腹胀痛、刺痛,热病神昏,癫痫发狂,黄疸尿赤。行气解郁,凉血破瘀。治胸腹胁肋诸痛,失心癫狂,热病神昏,吐血,衄血,尿血,血淋,妇女倒经,黄疸。《药性论》载其:治女人宿血气心痛,冷气结聚,温醋摩服之。《唐本草》载其:主血积,下气,生肌,止血,破恶血,血淋,尿血,金疮。
凌霄花性凉,味甘。入肺、胃、肝经。通络,活血,祛风。用于痹痛拘挛、胸胁胀痛、乳汁不通。《本草便读》:凌霄花,入经络,解邪热。热除则风去,络中津液不致结合而为痰,变成肿毒诸症,故云解毒耳。
夏枯草营养较为丰富,嫩茎叶中含有蛋白质、脂肪、碳水化合物、胡萝卜素、维生素B2、尼克酸和维生素C等成分。此外,还含有皂甙、芦丁、夏枯草甙、金丝桃甙及挥发油等。夏枯草性寒,味甘、辛、微苦,具有清泄肝火、散结消肿、清热解毒、祛痰止咳、凉血止血的功效,适用于淋巴结核、甲状腺肿、乳痈、头目眩晕、口眼歪斜、筋骨疼痛、肺结核、血崩、带下、急性传染性黄疸型肝炎及细菌性痢疾等。现代药理研究表明,夏枯草有降低血压的作用,并能扩张血管,其所含芦丁有抗炎作用,并能降低血管通透性,减少脆性,降低肝脂。夏枯草还有抵制癌细胞的作用。
佩兰解暑化湿,辟秽和中。主治感受暑湿;寒热头痛;湿润内蕴;脘痞不饥;恶心呕吐;口中甜腻;消洵.《本草经疏》:肺主气,肺气郁结,则上窍闭而下窍不通,胃主纳水谷,胃气郁滞,则水谷不以时化而为痰癖,兰草辛平能散结滞,芬芳能除秽恶,则上来诸证自瘳,大都开胃除恶,清肺消痰,散郁结之圣药也。《要药分剂》:兰草,为消痰除恶、散郁解结之品,《内经》消渴治之以兰,除陈气也。盖消渴由邪热郁结于胃,兰能除陈气。可知兰草固以荡涤为功,肃清肠胃者也。
桔梗粗皂苷有镇静、镇痛、解热作用,又能降血糖、降胆固醇,松弛平滑肌。桔梗皂苷有很强的溶血作用,但口服能在消化道中分解破坏而失去溶血作用。
绞股蓝经现代医学研究发现,绞股蓝主要有效成分为多糖类、黄酮类、皂苷类及微量元素类,其功效主要是促进人体脂肪类物质代谢、营养人体细胞,同时具有不错的解毒消炎作用,广泛应用于高血脂、脂肪肝、肥胖、便秘、失眠、乙肝、慢性呼吸道炎症(咽喉炎、肠胃炎等)的治疗与保健。
天花粉为葫芦科植物栝蒌的根,是一种中药,为清热泻火类药物,其具体功效是清热泻火,生津止渴,排脓消肿。主治:治热病口渴、消渴、黄疸、肺燥咳血、痈肿、痔痿。对于治疗糖尿病,常用它与滋阴药配合使用,以达到标本兼治的作用。《本草汇言》:天花粉,退五脏郁热,如心火盛而舌干口燥,肺火盛而咽肿喉痹,脾火盛而口舌齿肿,痰火盛而咳嗽不宁。若肝火之胁胀走注,肾火之骨蒸烦热,或痈疽已溃未溃,而热毒不散,或五疸身目俱黄,而小水若淋若涩,是皆火热郁结所致,惟此剂能开郁结,降痰火,并能治之。又其性甘寒,善能治渴,从补药而治虚渴,从凉药而治火渴,从气药而治郁渴,从血药而治烦渴,乃治渴之要药也。
桑寄生苦;甘;性平。入肝、肾经。补肝肾;强筋骨;祛风湿;安胎。主腰膝酸痛;筋骨痿弱;肢体偏枯;风湿痹痛;头错目眩;胎动不安,崩漏下血。用于风湿痹痛,腰膝酸软,筋骨无力,崩漏经多,妊娠漏血,胎动不安;高血压。《本经逢原》:寄生得桑之余气而生,性专祛风逐湿,通调血脉,故《本经》取治妇人腰痛,小儿背强等病,血脉通调而肌肤眉须皆受其荫,即有痈肿,亦得消散矣。《本草求真》:桑寄生,号为补肾补血要剂。缘肾主骨,发主血,苦人肾,肾得补则筋骨有力,不致屡痔而酸感矣。甘补血,血得补则发受其灌荫而不桔脱落矣。故凡内而腰痛、筋骨笃疾、胎堕,外而金疮、肌肤风湿,何一不借此以为主治乎。
凌霄花甘、酸,寒。归肝、心包经。花:凉血,化瘀,祛风。行血去瘀,凉血祛风。用于月经不调,经闭癓瘕,产后乳肿,风疹发红,皮肤瘙痒,痤疮。、《纲目》:凌雷花及根,甘酸而寒,茎叶带苦,行血分,能去血中伏火,故主产乳崩漏诸疾及血热生风之证也。《本草经疏》:紫藏,入肝行血之峻药,故主妇人产乳余疚,及崩中、额底、血闭塞热、赢瘦诸证;至于养胎,决非其性之所宜,用看慎之。
南五味子,别名红木香、紫金藤、紫荆皮、盘柱香、内红消、风沙藤、小血藤,拉丁文名Kadsuralongipedunculata,木兰科南五味子属植物南五味子KadsuralongepedunculataFinetetGagnep(K.peltigeraRehd.etWils.),藤本植物,各部无毛。收敛固涩,益气生津,补肾宁心。用于久嗽虚喘,梦遗滑精,遗尿尿频,久泻不止,自汗,盗汗,津伤口渴,短气脉虚,内热消渴,心悸失眠。
青蒿清透虚热,凉血除蒸,除蒸,截疟。用于暑邪发热,阴虚发热,夜热早凉,骨蒸劳热,疟疾寒热,湿热黄疸。该品苦寒清热,辛香透散,善使阴分伏热透达外散,为阴虚发热要药,此外兼有解暑,截虐之功。
具体实施例1:
先将葛根制备。
再将其余原料补骨脂,黄精,生地,桑寄生,丹参,党参,石韦,南五味子,女贞子,青蒿,凌霄花,茯苓,夏枯草,佩兰,桔梗,绞股蓝,天花粉,白术,提取浓缩制成颗粒剂、粉剂或膏剂。
制备好的葛根与其他原料的提取物颗粒剂,紫外线杀菌消毒装袋,使用时直接可以用开水冲服。
具体实施例2:
取当秋末冬初葛根果皮变红时采收果实,大约5000g,用文火烘或置沸水中略烫后,及时除去果核,干燥,晒干生山萸肉,放锅内隔水在80-100℃下蒸30-60分钟,蒸至紫褐色,然后晒干;将剩余原料补骨脂1500g,黄精1500g,生地1500g,桑寄生1500g,丹参1500g,党参1500g,石韦1500g,南五味子1500g,女贞子1500g,青蒿1500g,凌霄花1500g,茯苓1500g,夏枯草1500g,佩兰1500g,桔梗1500g,绞股蓝1500g,天花粉1500g,白术1500g,洗净去杂,泡入乙醇,加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述两种提取液合并,减压回收乙醇并浓缩至药液浓度为0.6g生药/mL,抽滤后,滤液的相对密度约为20℃时1.08;减压至0.03-0.08MPa,温度保持在60-80℃,浓缩至相对密度为1.20,温度至60℃-70℃的浸膏。上述步骤提取的浸膏置入双效真空浓缩器中,浓缩至90℃时相对密度为1.05的浓缩液,置0~5℃低温冷藏24小时;将冷藏液加0.3%的助滤剂硅藻土,过滤,滤液再置入双效真空浓缩器中,浓缩至每1ml含1g生药量,然后加糊精放入制粒机中制粒。将制备好的葛根与其他原料制备的颗粒物混合,紫外线灭菌,包装即得。
具体实施例3:
取当秋末冬初葛根果皮变红时采收果实,约3000g,用文火烘或置沸水中略烫后,及时除去果核,干燥,晒干后,生山萸肉放锅内隔水在80-100℃下蒸30-40分钟,蒸至紫褐色,然后晒干;再将剩余原料补骨脂1200g,黄精1300g,生地1200g,桑寄生1300g,丹参1200g,党参1300g,石韦1200g,南五味子1200g,女贞子1200g,青蒿1300g,凌霄花1200g,茯苓1200g,夏枯草1200g,佩兰1300g,桔梗1200g,绞股蓝1200g,天花粉1200g,白术1200g,将其放入10倍量水中浸泡。投入多功能提取罐提取两次,第一次加8-10倍量水煎煮1-2小时,第二次加4-8倍量水煎煮1-2小时,合并两次煎液,过滤得滤液;加热浓缩至粉末,然后放入烘箱内干燥成粉末,紫外线杀菌消毒后与炒制好的葛根混合包装,使用时直接开水冲服。
具体实施例4:
取当秋末冬初葛根果皮变红时采收果实,大约3500g,用文火烘或置沸水中略烫后,及时除去果核,干燥,晒干生山萸肉放锅内隔水在80-100℃下蒸30-50分钟,蒸至紫褐色,然后晒干;将剩余原料补骨脂1200g,黄精1300g,生地1200g,桑寄生1100g,丹参1200g,党参1300g,石韦1300g,南五味子1200g,女贞子1200g,青蒿1300g,凌霄花1300g,茯苓1100g,夏枯草1200g,佩兰1300g,桔梗1200g,绞股蓝1100g,天花粉1200g,白术1300g;将其他原料放入5-10倍量乙醇中,浸泡1-2小时,加热提取2次,每次1-2小时,去上清液,合并提取液,100-120目滤过;再将上述乙醇提取过的其他原料药的药渣加10倍量水加热回流提取2次,每次1~2小时,将2次提取液合并静置;将上述两种提取液合并,减压回收乙醇,并浓缩至药液浓度为0.6g生药/mL,抽滤后,滤液的相对密度约为20℃时1.08;减压至0.03-0.08MPa,温度保持在60-80℃,浓缩至相对密度为1.20,温度至60℃-70℃的浸膏;紫外线杀菌消毒后与炒制好的葛根混合包装,使用时直接开水冲服。
Claims (3)
1.一种可降压降糖降脂的葛根保健茶,其特征在于,所述保健茶的各种原料的重量份数包括:葛根10~50份,补骨脂10~20份,黄精10~20份,生地10~20份,桑寄生10~20份,丹参10~20份,党参10~20份,石韦10~20份,南五味子10~20份,女贞子10~20份,青蒿10~20份,凌霄花10~20份,茯苓10~20份,夏枯草10~20份,佩兰10~20份,桔梗10~20份,绞股蓝10~20份,天花粉10~20份,白术10~20份。
2.根据权利要求1所述可降压降糖降脂的葛根保健茶,其特征在于,所述保健茶的各种原料的重量份数包括:葛根10~50份,补骨脂10~15份,黄精10~15份,生地10~15份,桑寄生10~15份,丹参10~15份,党参10~15份,石韦10~15份,南五味子10~15份,女贞子10~15份,青蒿10~20份,凌霄花10~20份,茯苓10~20份,夏枯草10~20份,佩兰10~20份,桔梗10~20份,绞股蓝10~20份,天花粉10~20份,白术10~20份。
3.根据权利要求1所述可降压降糖降脂的葛根保健茶,其特征在于,所述保健茶的各种原料的重量份数包括:葛根10~50份,补骨脂10~20份,黄精10~20份,生地10~20份,桑寄生10~20份,丹参10~20份,党参10~20份,石韦10~20份,南五味子10~20份,女贞子10~20份,青蒿10~15份,凌霄花10~15份,茯苓10~15份,夏枯草10~15份,佩兰10~15份,桔梗10~15份,绞股蓝10~15份,天花粉10~15份,白术10~15份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510856670.8A CN105394282A (zh) | 2015-11-29 | 2015-11-29 | 一种可降压降糖降脂的葛根保健茶 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510856670.8A CN105394282A (zh) | 2015-11-29 | 2015-11-29 | 一种可降压降糖降脂的葛根保健茶 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105394282A true CN105394282A (zh) | 2016-03-16 |
Family
ID=55460332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510856670.8A Pending CN105394282A (zh) | 2015-11-29 | 2015-11-29 | 一种可降压降糖降脂的葛根保健茶 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105394282A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107261015A (zh) * | 2017-06-21 | 2017-10-20 | 佛山科学技术学院 | 一种降压冲剂及其制备方法 |
| CN107259450A (zh) * | 2017-06-29 | 2017-10-20 | 杨胜 | 一种降压降糖南瓜藤及其制作方法 |
| CN107496697A (zh) * | 2017-08-23 | 2017-12-22 | 广西桂平市石龙镇江夏种养专业合作社 | 一种降脂桑寄生药茶 |
-
2015
- 2015-11-29 CN CN201510856670.8A patent/CN105394282A/zh active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107261015A (zh) * | 2017-06-21 | 2017-10-20 | 佛山科学技术学院 | 一种降压冲剂及其制备方法 |
| CN107259450A (zh) * | 2017-06-29 | 2017-10-20 | 杨胜 | 一种降压降糖南瓜藤及其制作方法 |
| CN107496697A (zh) * | 2017-08-23 | 2017-12-22 | 广西桂平市石龙镇江夏种养专业合作社 | 一种降脂桑寄生药茶 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102988638B (zh) | 一种青钱柳叶降脂降糖保健茶及其制备方法 | |
| CN103039668B (zh) | 一种葛根丰胸茶及其制备方法 | |
| CN103053748B (zh) | 一种葛根降脂降糖保健茶及其制备方法 | |
| CN103690783B (zh) | 用于治疗糖尿病的中药制剂及其制备方法 | |
| CN103719494B (zh) | 一种牛蒡子通便润肠保健茶及其制备方法 | |
| CN103749822A (zh) | 一种女贞子降压降脂保健茶及其制备方法 | |
| CN103735835A (zh) | 一种治疗少白头的中药制剂及其制备方法 | |
| CN103719495B (zh) | 一种牛蒡子降糖降脂保健茶及其制备方法 | |
| CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
| CN103749819B (zh) | 一种降糖降脂的山茱萸保健茶及其制备方法 | |
| CN104905267A (zh) | 一种决明子降血脂保健口服液及其制备方法 | |
| CN105664099A (zh) | 一种温补肾阳的中药组合物及其制备方法 | |
| CN103749824A (zh) | 一种绞股蓝降糖降压保健茶及其制备方法 | |
| CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
| CN105394282A (zh) | 一种可降压降糖降脂的葛根保健茶 | |
| CN104304602A (zh) | 一种软化血管的槐角茶及其制备方法 | |
| CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
| CN105341944A (zh) | 一种提高免疫力的丹参口服液及其制备方法 | |
| CN105494781A (zh) | 一种虎杖降糖降脂保健茶 | |
| CN105012873A (zh) | 一种降血脂的月见草保健口服液及其制备方法 | |
| CN105455125A (zh) | 一种提高免疫力的龙眼肉口服液及其制备方法 | |
| CN105410268A (zh) | 一种明目降脂的菟丝子保健茶及其制备方法 | |
| CN104524479B (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
| CN105381220A (zh) | 一种明目降脂的菟丝子保健茶 | |
| CN103223137B (zh) | 一种降血糖的中药制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160316 |